For Medical Professionals

News for Medical Professionals

OncLive Panel Discussion on Brentuximab Vedotin in CD30-Positive Lymphoma

March 2014 - Panelists Myron S. Czuczman, MD, (Roswell Park) Steve M. Horwitz, MD, (MSKCC), Lauren C. Pinter-Brown, MD, (UCLA), Andrei R. Shustov, MD, (SCCA) and Anas Younes, MD, (MSKCC) discuss the approval of brentuximab vedotin for patients with systemic anaplastic large-cell lymphoma and the continued investigation of the drug in other CD30-positive lymphoid malignancies on episode of OncLive.

Watch the video of their discussion here: http://www.onclive.com/peer-exchange/lymphoma/Brentuximab-Vedotin-in-CD3...


Brentuximab Vedotin in CD30-Positive Lymphoma
Brentuximab Vedotin in CD30-Positive Lymphoma

Archived News for Medical Professionals

English French German Italian Portuguese Russian Spanish

This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.